Hemopharm GmbH manufactures chemical-pharmaceutical products, conducts import and export as well as distribution and trade of medical devices and hospital supplies, and worldwide markets products of Hemofarm A.D. (purpose of the company). The company is fully integrated into the STADA group, receives targets from group management and acts in Bad Vilbel as a central service and supply-chain company for the country subsidiaries in Bulgaria, Hungary, Croatia and Slovenia. In the 2017 financial year Hemopharm GmbH recorded net revenues of EUR 24,733k and a net profit of EUR 2,174k; Bulgaria contributed 49.17% and Hungary 20.23% of net sales. On average 8 employees worked in administration and the equity ratio increased in 2017 to 13.8% (equity EUR 2,891k).
Herstellung, der Im- und Export sowie der Vertrieb und Handel mit chemisch-pharmazeutischen Erzeugnissen, medizinischen Geräten, Gegenständen für den Krankenhausbedarf, Ausrüstungen für die pharmazeutische Industrie einschließlich der weltweiten Vermarktung der Produkte der Fa. Hemofarm D.D.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 110744 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Frank Seiler | Geschäftsführer(in) | Frankfurt am Main |
| Ioanna Sotirakou | Geschäftsführer(in) | Bad Vilbel |
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 110744 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2017 | €24,733,062 | €2,178,211 | €20,902,527 | — |
| 2016 | €25,974,810 | €751,952 | €13,738,042 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 110744 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Depreciation | €129,227 | 32.9% |
| Interest & Similar | €263,216 | 67.1% |
